ARK Invest sold a combined $2.57 million in crypto-linked equities on April 17, exiting positions in Circle Internet Group (CIRC) and Bullish (BLSH). At the same time, the firm rotated into Netflix (NFLX) after its post-earnings slide and Alamar Biosciences (ALMR) on its first day of trading, following a notable jump from its IPO price.
How ARK Shifted its Portfolio: Crypto Sells, Streaming and Biotech Buys
According to regulatory filings, ARK sold 11,465 shares of Circle Internet Group worth $1.21 million and 31,417 shares of Bullish worth $1.36 million on April 17, closing out both positions. Circle Internet Group, issuer of the USDC stablecoin, has been under scrutiny for its response to the Drift Protocol exploit earlier in the month and is now facing a class-action lawsuit. On April 17, Circle shares ended the session down 1.44% at $105.91. Bullish, a crypto exchange backed by PayPal co-founder Peter Thiel, saw its stock rise 5% to close at $43.51 amid a broader market recovery linked to optimism in West Asia, but ARK used the rally to sell its position.
On the buying side, ARK acquired 26,161 shares of Netflix worth $2.54 million after Netflix reported Q1 revenue of $12.25 billion and profit of $5.28 billion, numbers that topped expectations but still saw the shares fall 9.72% to $97.31 on April 17. ARK also bought 537,463 shares of Alamar Biosciences worth $11.96 million as the Fremont-based company debuted on Nasdaq. Alamar shares opened at $22.60 against an offer price of $17 and closed with a $1.53 billion valuation after a 33% jump, per filings.
Stocks365 Take: A Targeted Rotation Amid Market Volatility
ARK's inactivity in crypto and related equities on April 14 and 15, as reported, followed by concentrated trades on April 17, highlights a purposeful approach to portfolio adjustments. The previous sale of Robinhood shares worth $12.7 million on April 7 and the subsequent focus on select opportunities in streaming and biotech, as seen with Netflix and Alamar, underscore continued interest in growth sectors when valuation or debut volatility creates entry points. Alamar’s 33% Nasdaq debut rally highlights market appetite for new life sciences platforms; Netflix’s post-earnings selloff offered ARK an entry point into a sector leader after measured disappointment in headline beats.
What to Watch: Litigation for Circle, Valuation for Netflix, and IPO Sentiment
Circle’s regulatory and legal situation, especially potential fallout from the Drift Protocol exploit and linked class-action suit, remains a material development for stablecoin-exposed investors. For Netflix, the near-term focus is on whether shares can recover above the Q1 closing level of $97.31 — a key barometer for sentiment following the earnings decline. Alamar’s second week of trading will test market conviction in new biotech listings, while ARK’s larger-than-average debut participation will be scrutinized for signals about appetite and risk tolerance among prominent growth investors.
